Investigating of the side effects of covid-۱۹ vaccines in Southern Iran: a cross-sectional study

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 37

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ARCHRAZI-79-1_016

تاریخ نمایه سازی: 19 اردیبهشت 1403

Abstract:

The Covid-۱۹ disease is a newly emerging disease, and the covid-۱۹ vaccine is one of the necessities to prevent this disease. The present study aimed to Investigate the side effects of covid-۱۹ vaccines in southern Iran. We used convenience sampling to conduct this cross-sectional study on ۶۴۷ people living in cities under the coverage in southern Iran, Kerman. The data collection tool included a researcher-maid questionnaire of vaccine symptoms and signs. The results were analyzed by SPSS software version ۲۴ and ANOVA, and chi-square tests. The mean age of the participants was ۴۰.۱۹±۱۵.۲۰. The results indicated that ۴۳۱ people (۶۶.۶%) reported post-vaccination side effects, with ۱۸.۲۳% of them having severe side effects. We noticed the most severe side effects in AstraZeneca, Sinopharm, Sputnik, and Bharat. Fever, headache, and pain at the injection site were the most common side effects after vaccination respectively, which had a statistically significant relationship with all types of vaccines (P=۰.۰۰۱). The side effects differed in the types of vaccines and most of the vaccines had mild to moderate side effects. People with B blood type showed the most severe side effects while those with AB showed the lowest rate of side effects. Therefore, the injection of the AstraZeneca vaccine in blood group B should be done with more caution. And it is recommended more attention should be paid to blood groups B and A in the injection of Covid-۱۹ vaccines. also, health officials and the government should plan appropriate educational strategies to increase public knowledge and the importance of vaccines in eradicating viral infections

Authors

Shobeir Rostami Abusaeedi

School of Medicine, Imam Khomeini Hospital, Jiroft University of Medical Sciences

Ali Asghar Kheirkhah Vakilabad

School of Medicine, Imam Khomeini Hospital, Jiroft University of Medical Sciences

Ehsan Movahed

Department of Health, Jiroft University of Medical University, Jiroft, Iran

Moradali Zareipour

Department of Public Health, School of Health, Khoy University of Medical Sciences, Khoy, Iran

Vahid Mashayekhi

Jiroft University of Medical University, Jiroft, Iran

Shohreh Shafiei

Clinical Research Development Center of Imam Khomeini Hospital, Jiroft University of Medical Sciences, Jiroft, Iran

Yasin Sohrani

Clinical Research Development Unit, Imam Khomeini Hospital, Jiroft University of Medical Sciences, Jiroft, Iran

Hossein Rafeie

Postgraduate student of epidemiology،Clinical Research Development unit of Imam Khomeini Hospital, Jiroft University of Medical Sciences, Jiroft , Iran

Fereshte Gheyabi

Msc in a health education, Jiroft University of Medical Sciences, Jiroft, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • References۱. Jung F, Krieger V, Hufert F, Küpper J-H. Herd ...
  • Sharma O, Sultan AA, Ding H, Triggle CR. A Review ...
  • Cohen MS, Corey L. Combination prevention for COVID-۱۹ ...
  • American Association for the Advancement of Science; ۲۰۲۰ ...
  • Steele AD, Patel M, Parashar UD, Victor JC, Aguado T,Neuzil ...
  • Gee J, Marquez P, Su J, Calvert GM, Liu R, ...
  • The first month of COVID-۱۹ vaccine safety monitoring—United States, December ...
  • Morbidity and mortality weekly report. ۲۰۲۱;۷۰(۸):۲۸۳ ...
  • Soiza RL, Scicluna C, Thomson EC. Efficacy and safety ofCOVID-۱۹ ...
  • Anderson PO. Maternal vaccination and breastfeeding ...
  • Breastfeeding Medicine. ۲۰۱۹;۱۴(۴):۲۱۵-۷ ...
  • Hughes BL, Swamy G, Eckert LON, Gyamq‐Bannerman C,Turrentine M. Vaccinating ...
  • Mehrotra DV, Janes HE, Fleming TR, Annunziato PW,Neuzil KM, Carpp ...
  • Wang X. Safety and efficacy of the BNT۱۶۲b۲ mRNACovid-۱۹ vaccine. ...
  • Alessa MY, Aledili FJ, Alnasser AA, Aldharman SS, AlDehailan AM, ...
  • Hatmal MmM, Al-Hatamleh MA, Olaimat AN, Hatmal M,Alhaj-Qasem DM, Olaimat ...
  • Aliberti SM, Schiavo L, Boccia G, Santoro E, Franci G,Ruggiero ...
  • Chew NW, Cheong C, Kong G, Phua K, Ngiam JN, ...
  • Amit S, Regev-Yochay G, Afek A, Kreiss Y, Leshem E ...
  • Early rate reductions of SARS-CoV-۲ infection and COVID۱۹ in BNT۱۶۲b۲ ...
  • El-Shitany NA, Harakeh S, Badr-Eldin SM, Bagher AM,Eid B, Almukadi ...
  • ۱۵۸ Rostami Abusaeedi et al / Archives of Razi Institute, ...
  • Kashte S, Gulbake A, El-Amin III SF, Gupta A. COVID-۱۹vaccines: ...
  • Nikbakht G. Novel Insights into Infection and Immunity ...
  • Iranian Journal of Veterinary Medicine. ۲۰۲۲;۱۶(۲):۹۹-۱۰۰ ...
  • Van Doremalen N, Lambe T, Spencer A, BelijRammerstorfer S, Purushotham ...
  • Wang H, Zhang Y, Huang B, Deng W, Quan Y, ...
  • ۲۰۲۰;۱۸۲(۳):۷۱۳-۲۱. e۹ ...
  • Wise J. Covid-۱۹: European countries suspend use ofOxford-AstraZeneca vaccine after ...
  • British Medical Journal Publishing Group; ۲۰۲۱ ...
  • Bhattacharjee S, Banerjee M. Immune thrombocytopeniasecondary to COVID-۱۹: a systematic ...
  • Abu-Farha RK, Alzoubi KH, Khabour OF. Publicwillingness to participate in ...
  • Allan JD, McMillan D, Levi ML, McMillan DT. COVID-۱۹mRNA Vaccination, ...
  • Enguita-Germán M, Librero J, Leache L, Gutiérrez-ValenciaM, Tamayo I, Jericó ...
  • نمایش کامل مراجع